12 HR ranolazine 500 MG Extended Release Oral Tablet

1 INDICATIONS AND USAGE Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine is an antianginal indicated for the treatment of chronic angina. ( 1 )

ajanta pharma limited

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] pain` `[5] off label use` `[6] headache` `[7] diarrhoea` `[8] dizziness` `[9] dyspnoea` `[10] fall`

4 years ago

OVAL ORANGE RZ1

16 HOW SUPPLIED/STORAGE AND HANDLING

RANOLAZINE extended-release tablets are supplied as film-coated, oval-shaped, biconvex, extended-release tablets in the following strengths: 500 mg tablets are orange colored, with RZ1 on one side and plain on other side 1000 mg tablets are yellow colored, with RZ2 on one side and plain on other side

RANOLAZINE extended-release tablets are available in: Strength NDC Unit-of-Use Bottle (60 Tablets) 500 mg 27241-125-02 Bottle (500 Tablets) 500 mg 27241-125-05 Unit-of-Use Bottle (60 Tablets) 1000 mg 27241-126-02 Bottle (500 Tablets) 1000 mg 27241-126-05 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]

More pills like OVAL RZ1

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

12 HR ranolazine 500 MG Extended Release Oral Tablet

FDA Reported Adverse Reactions [1] drug ineffective [2] fatigue [3] nausea [4] pain [5] off label use [6] headache [7] diarrhoea [8] dizziness [9] dyspnoea [10] fall

OVAL ORANGE RZ1

More pills like OVAL RZ1

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] pain` `[5] off label use` `[6] headache` `[7] diarrhoea` `[8] dizziness` `[9] dyspnoea` `[10] fall`